• Stars are making bold statements about cannabis acceptance, efficacy as they enter cannabis business
• Lofty product claims may be seen as marketing ploys, but experts say there can be wellness benefits
• PACR’s strong focus, dedication differentiates it from other cannabis offerings, even those from big-name players in the cannabis space

A growing number of celebrities are throwing their weight behind cannabis, an undeniable indication of the increasing acceptance of the compound — both as a medical and recreational option. A recent “USA Today” article notes that as more states legalize marijuana, more eyes are turning toward the industry, a trend that leading cannabis companies such as Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) are in position to benefit from.

“What do Martha Stewart, Jay-Z and Jaleel White (aka Steve Urkel) have in common?” the “USA Today” article asks. “They’re all in the cannabis business. They’re among many stars, including Snoop Dogg and Seth Rogen, who have joined the industry in recent years and are making bold statements with their products. Stewart’s self-named brand of CBD gummies claims to ‘make wellness an easier choice, every day,’ and Rogen’s Houseplant strain THC promises to give a ‘smooth, warm and calming experience.’

“These lofty product claims may be seen as marketing ploys in an increasingly competitive industry, but experts say there can be wellness benefits to some of these products,” states the article, which mentions that Kristen Bell, Willie Nelson, Gwyneth Paltrow and “Crazy Rich Asians” actor Jimmy O. Yang have also lent their names to cannabis products. 

Most celebrities are careful about what products they endorse, and the “USA Today” article notes that both cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”), cannabinoids found in the marijuana plant, may be beneficial. The article quotes Washington, DC, MD Patricia Frye, who says both CBD and THC can help with sleep, anxiety, metabolism, stress and appetite. “These cannabinoids are so helpful, (because) people are starting to move away from a lot of pharmaceuticals,” Frye says. 

“Overall, it’s a lot safer than anything else you’d be using if you’re using it instead of opioids for pain or Ambien to help you sleep or instead of benzodiazepine for anxiety,” agreed Dr. Peter Grinspoon, a Harvard Medical School professor and a primary care doctor at Massachusetts General Hospital. 

Pac Roots Cannabis is a Canadian company dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach. The company’s commitment to quality and excellence is evident in its mantra of “quality over quantity” (https://ibn.fm/em2AR). Pac Roots is focused on elite genetic development and maximizes the quality of its offerings by keeping yields and profit margins high. The company also leverages key partnerships to ensure the superiority of its products. Those partnership include Phenome One, which has built one of the largest live genetic libraries in Canada, with more than 350 live cultivars; and Rock Creek Farms and Speakeasy Cannabis Club, both which provide existing infrastructure, equipment and access to land.

“Our mission is to deliver the finest genetics to Canadians,” the company states. “Preserving the excellence of our elite strains while introducing the highest quality of new strains to the public is our passion. Genetic variation and stability are the foundation that drives the decision making for our business.” Such strong focus and dedication is sure to differentiate Pac Roots Cannabis — even setting it apart from the big-name players in the cannabis space. 

For more information, visit the company’s website at www.PacRoots.ca.

NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://ibn.fm/PACR

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.